← All organizations

Pharmbio Korea

For profitWebsite ↗

Also known as: Pharmbio Korea | Pharmbio Korea Co., Ltd. | Pharmbio Korea Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Aug 31, 2025

Timeline

1990s

Jan 1, 1999
Pharmbio Korea— Founded

Drugs by trial phase (23 distinct, 18 trials)

Phase 4 (11 own, 0 via acquisition)

Phase 3 (7 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (3 own, 0 via acquisition)

Indications

Studied for

Recent trials (18)

NCT07114406Lead sponsorPhase 3Aug 31, 2025
NCT07017335Lead sponsorPhase 1Jun 1, 2025
NCT06154187Lead sponsorPhase 3Feb 29, 2024
NCT05923918Lead sponsorPhase 3Jun 30, 2023
NCT05299411CollaboratorPhase 2Apr 20, 2023
NCT05509868Lead sponsorPhase 3Jul 20, 2022
NCT05249335Lead sponsorPhase 4Feb 28, 2022
NCT04450355CollaboratorN/AJul 1, 2020
NCT04418388Lead sponsorPhase 1Oct 24, 2019
NCT03509220Lead sponsorPhase 3Apr 11, 2018
NCT02761213CollaboratorPhase 4Apr 1, 2016
NCT02882347CollaboratorPhase 3Jul 1, 2015
NCT02127021CollaboratorPhase 4Apr 1, 2014
NCT01765465CollaboratorPhase 4Jan 1, 2013
NCT01543165CollaboratorPhase 4Dec 1, 2012

Details

Founded: Seoul, KR Jan 1, 1999
Last known activity: Aug 31, 2025